These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 8108140)
21. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas. Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478 [TBL] [Abstract][Full Text] [Related]
22. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. Lang FF; Miller DC; Koslow M; Newcomb EW J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151 [TBL] [Abstract][Full Text] [Related]
23. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Sidransky D; Mikkelsen T; Schwechheimer K; Rosenblum ML; Cavanee W; Vogelstein B Nature; 1992 Feb; 355(6363):846-7. PubMed ID: 1311419 [TBL] [Abstract][Full Text] [Related]
24. Expression of Fas/APO-1 during the progression of astrocytomas. Tachibana O; Nakazawa H; Lampe J; Watanabe K; Kleihues P; Ohgaki H Cancer Res; 1995 Dec; 55(23):5528-30. PubMed ID: 7585627 [TBL] [Abstract][Full Text] [Related]
25. Influence of p53 mutations on prognosis of patients with glioblastoma. Shiraishi S; Tada K; Nakamura H; Makino K; Kochi M; Saya H; Kuratsu J; Ushio Y Cancer; 2002 Jul; 95(2):249-57. PubMed ID: 12124823 [TBL] [Abstract][Full Text] [Related]
26. Expression and mutation analysis of the p53 gene in astrocytoma. Hwang SL; Hong YR; Sy WD; Chai CY; Lin HJ; Howng SL J Formos Med Assoc; 1999 Jan; 98(1):31-8. PubMed ID: 10063271 [TBL] [Abstract][Full Text] [Related]
27. PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Rasheed BK; Stenzel TT; McLendon RE; Parsons R; Friedman AH; Friedman HS; Bigner DD; Bigner SH Cancer Res; 1997 Oct; 57(19):4187-90. PubMed ID: 9331072 [TBL] [Abstract][Full Text] [Related]
28. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors. Ren ZP; Olofsson T; Qu M; Hesselager G; Soussi T; Kalimo H; Smits A; Nistér M J Neuropathol Exp Neurol; 2007 Oct; 66(10):944-54. PubMed ID: 17917588 [TBL] [Abstract][Full Text] [Related]
29. p53 abnormality and tumor invasion in patients with malignant astrocytoma. Momota H; Narita Y; Matsushita Y; Miyakita Y; Shibui S Brain Tumor Pathol; 2010 Oct; 27(2):95-101. PubMed ID: 21046311 [TBL] [Abstract][Full Text] [Related]
30. Brainstem gliomas--a clinicopathological study of 45 cases with p53 immunohistochemistry. Badhe PB; Chauhan PP; Mehta NK Indian J Cancer; 2004; 41(4):170-4. PubMed ID: 15659871 [TBL] [Abstract][Full Text] [Related]
31. Absence of p53 autoantibodies in sera from glioma patients. Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045 [TBL] [Abstract][Full Text] [Related]
33. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413 [TBL] [Abstract][Full Text] [Related]
34. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis. Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773 [TBL] [Abstract][Full Text] [Related]
35. Expression of the p53 protein in a spectrum of astrocytic tumours. Ellison DW; Gatter KC; Steart PV; Lane DP; Weller RO J Pathol; 1992 Dec; 168(4):383-6. PubMed ID: 1336544 [TBL] [Abstract][Full Text] [Related]
36. The retinoblastoma gene is involved in malignant progression of astrocytomas. Henson JW; Schnitker BL; Correa KM; von Deimling A; Fassbender F; Xu HJ; Benedict WF; Yandell DW; Louis DN Ann Neurol; 1994 Nov; 36(5):714-21. PubMed ID: 7979217 [TBL] [Abstract][Full Text] [Related]
37. p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas. Patt S; Gries H; Giraldo M; Cervos-Navarro J; Martin H; Jänisch W; Brockmöller J Hum Pathol; 1996 Jun; 27(6):586-9. PubMed ID: 8666369 [TBL] [Abstract][Full Text] [Related]
38. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844 [TBL] [Abstract][Full Text] [Related]
39. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma. Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740 [TBL] [Abstract][Full Text] [Related]
40. TP53 mutations in astrocytic gliomas: an association with histological grade, TP53 codon 72 polymorphism and p53 expression. Faria MH; Neves Filho EH; Alves MK; Burbano RM; de Moraes Filho MO; Rabenhorst SH APMIS; 2012 Nov; 120(11):882-9. PubMed ID: 23009112 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]